Magnetic Sentinel Lymph Node Biopsy

The future of cancer staging

Sentinel Lymph Node Biopsy

Sentinel Lymph Node Biopsy (SLNB) has been widely accepted as the replacement for axillary lymph node dissection as the staging procedure for early node-negative breast cancer. Traditionally SLNB involves injecting radioactive drugs which are dependent on nuclear medicine availability and blue dyes that can put a patient at risk for anaphylaxis and skin necrosis.1,2

Magnetic Sentinel Lymph Node Biopsy

Magnetic SLNB uses a single tracer that offers the freedom to be injected in the operating room or up to seven days beforehand to improve scheduling and the patient experience.

MAGNETIC SENTINEL LYMPH NODE BIOPSY WITH THE SENTIMAG ONE-PLATFORM

Magtrace® Lymphatic Tracer

Magtrace® is a magnetic tracer that is engineered to be uniform and small enough for rapid migration, yet large enough to be mechanically filtered by the sentinel lymph nodes.

Learn More

Would you like more information about a product?